List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gabapentin Revenue
1.4 Market Analysis by Type
1.4.1 Global Gabapentin Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Capsule
1.4.3 Tablet
1.5 Market by Application
1.5.1 Global Gabapentin Market Share by Application: 2022-2027
1.5.2 Epilepsy
1.5.3 Neuropathic Pain
1.5.4 Restless Legs Syndrome
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Gabapentin Market
1.8.1 Global Gabapentin Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Gabapentin Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Gabapentin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gabapentin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gabapentin Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Gabapentin Sales Volume Market Share by Region (2016-2021)
3.2 Global Gabapentin Sales Revenue Market Share by Region (2016-2021)
3.3 North America Gabapentin Sales Volume
3.3.1 North America Gabapentin Sales Volume Growth Rate (2016-2021)
3.3.2 North America Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Gabapentin Sales Volume
3.4.1 East Asia Gabapentin Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Gabapentin Sales Volume (2016-2021)
3.5.1 Europe Gabapentin Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Gabapentin Sales Volume (2016-2021)
3.6.1 South Asia Gabapentin Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Gabapentin Sales Volume (2016-2021)
3.7.1 Southeast Asia Gabapentin Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Gabapentin Sales Volume (2016-2021)
3.8.1 Middle East Gabapentin Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Gabapentin Sales Volume (2016-2021)
3.9.1 Africa Gabapentin Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Gabapentin Sales Volume (2016-2021)
3.10.1 Oceania Gabapentin Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Gabapentin Sales Volume (2016-2021)
3.11.1 South America Gabapentin Sales Volume Growth Rate (2016-2021)
3.11.2 South America Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Gabapentin Sales Volume (2016-2021)
3.12.1 Rest of the World Gabapentin Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Gabapentin Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Gabapentin Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Gabapentin Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Gabapentin Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Gabapentin Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Gabapentin Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Gabapentin Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Gabapentin Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Gabapentin Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Gabapentin Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Gabapentin Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Gabapentin Sales Volume Market Share by Type (2016-2021)
14.2 Global Gabapentin Sales Revenue Market Share by Type (2016-2021)
14.3 Global Gabapentin Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Gabapentin Consumption Volume by Application (2016-2021)
15.2 Global Gabapentin Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Gabapentin Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Gabapentin Product Specification
16.1.3 Pfizer Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Assertio Therapeutics
16.2.1 Assertio Therapeutics Company Profile
16.2.2 Assertio Therapeutics Gabapentin Product Specification
16.2.3 Assertio Therapeutics Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 TEVA
16.3.1 TEVA Company Profile
16.3.2 TEVA Gabapentin Product Specification
16.3.3 TEVA Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Mylan
16.4.1 Mylan Company Profile
16.4.2 Mylan Gabapentin Product Specification
16.4.3 Mylan Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Arbor Pharma
16.5.1 Arbor Pharma Company Profile
16.5.2 Arbor Pharma Gabapentin Product Specification
16.5.3 Arbor Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Novartis
16.6.1 Novartis Company Profile
16.6.2 Novartis Gabapentin Product Specification
16.6.3 Novartis Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Apotex
16.7.1 Apotex Company Profile
16.7.2 Apotex Gabapentin Product Specification
16.7.3 Apotex Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Sun Pharmaceutical
16.8.1 Sun Pharmaceutical Company Profile
16.8.2 Sun Pharmaceutical Gabapentin Product Specification
16.8.3 Sun Pharmaceutical Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Aurobindo Pharma
16.9.1 Aurobindo Pharma Company Profile
16.9.2 Aurobindo Pharma Gabapentin Product Specification
16.9.3 Aurobindo Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Intas
16.10.1 Intas Company Profile
16.10.2 Intas Gabapentin Product Specification
16.10.3 Intas Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Amneal
16.11.1 Amneal Company Profile
16.11.2 Amneal Gabapentin Product Specification
16.11.3 Amneal Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Marksans Pharma
16.12.1 Marksans Pharma Company Profile
16.12.2 Marksans Pharma Gabapentin Product Specification
16.12.3 Marksans Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Glenmark
16.13.1 Glenmark Company Profile
16.13.2 Glenmark Gabapentin Product Specification
16.13.3 Glenmark Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Alkem
16.14.1 Alkem Company Profile
16.14.2 Alkem Gabapentin Product Specification
16.14.3 Alkem Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Jiangsu Enhua
16.15.1 Jiangsu Enhua Company Profile
16.15.2 Jiangsu Enhua Gabapentin Product Specification
16.15.3 Jiangsu Enhua Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Jiangsu Hengrui
16.16.1 Jiangsu Hengrui Company Profile
16.16.2 Jiangsu Hengrui Gabapentin Product Specification
16.16.3 Jiangsu Hengrui Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Sailike
16.17.1 Sailike Company Profile
16.17.2 Sailike Gabapentin Product Specification
16.17.3 Sailike Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Gabapentin Manufacturing Cost Analysis
17.1 Gabapentin Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Gabapentin
17.4 Gabapentin Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Gabapentin Distributors List
18.3 Gabapentin Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Gabapentin (2022-2027)
20.2 Global Forecasted Revenue of Gabapentin (2022-2027)
20.3 Global Forecasted Price of Gabapentin (2016-2027)
20.4 Global Forecasted Production of Gabapentin by Region (2022-2027)
20.4.1 North America Gabapentin Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Gabapentin Production, Revenue Forecast (2022-2027)
20.4.3 Europe Gabapentin Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Gabapentin Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Gabapentin Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Gabapentin Production, Revenue Forecast (2022-2027)
20.4.7 Africa Gabapentin Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Gabapentin Production, Revenue Forecast (2022-2027)
20.4.9 South America Gabapentin Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Gabapentin Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Gabapentin by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Gabapentin by Country
21.2 East Asia Market Forecasted Consumption of Gabapentin by Country
21.3 Europe Market Forecasted Consumption of Gabapentin by Countriy
21.4 South Asia Forecasted Consumption of Gabapentin by Country
21.5 Southeast Asia Forecasted Consumption of Gabapentin by Country
21.6 Middle East Forecasted Consumption of Gabapentin by Country
21.7 Africa Forecasted Consumption of Gabapentin by Country
21.8 Oceania Forecasted Consumption of Gabapentin by Country
21.9 South America Forecasted Consumption of Gabapentin by Country
21.10 Rest of the world Forecasted Consumption of Gabapentin by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
